Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8 Clinical Trials
3 recruiting trials for Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8 clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by National Cancer Institute (NCI) (1), Mayo Clinic (1), Emory University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Biospecimen Collection (procedure, 2 trials), followed by Computed Tomography, Magnetic Resonance Imaging.
Track Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8 trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or...
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and...
Oropharynx (OPX) Biomarker Trial
The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist...
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
This phase II trial tests how well lovastatin and pembrolizumab work in treating patients with head and neck cancer that has come back after a period of improvement (recurrent) or...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Clinical Stage Iv Hpv-Mediated (p16-Positive) Oropharyngeal Carcinoma Ajcc v8, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.